RESEARCH BASE
Search 3,717 documents across 34 fields — every claim tier-rated by evidence
175 results for "psychedelic therapy regulation" — page 2 of 9
Z_1_19 — Non-Coding RNA and Gene Regulation
Non-coding RNAs (ncRNAs) — RNA molecules that are transcribed from the genome but do not encode proteins — have emerged as central regulators of gene expression, challenging the classical "one gene–one protein" paradigm
Z_4_17 — Non-coding RNA Networks: Regulation Beyond the Genome
Non-coding RNAs (ncRNAs) — RNA molecules that are not translated into protein but perform functional roles in the cell — have emerged since the late 1990s as a vast and previously unsuspected layer of biological regulati
Mind_Body_Healing_Frontier
The scientific investigation of mind-body interactions has progressed from fringe speculation to a major research domain supported by institutional infrastructure (National Center for Complementary and Integrative Health
INTERDOC_20 — Psychedelic Neuroscience and Ancient Ritual Practice
[KEY FINDING] The Johns Hopkins Center for Psychedelic and Consciousness Research, the Imperial College Centre for Psychedelic Research (est. 2019, directed by Robin Carhart-Harris), and the MAPS (Multidisciplinary Assoc
O_5_16 — Gaia Hypothesis and Earth System Self-Regulation
The Gaia hypothesis, proposed by James Lovelock (atmospheric chemist, 1919–2022) and co-developed with Lynn Margulis (microbiologist, 1938–2011), posits that Earth's biosphere, atmosphere, oceans, and geosphere interact
Y_1_11 — Ketamine: Dissociative Anesthetic and Consciousness Explorer
Ketamine is a dissociative anesthetic — first synthesized by Calvin Stevens in 1962 and introduced into clinical use by Edward Domino and Guenter Corssen (1966) — that has undergone a remarkable transformation from battl
Y_1_06 — Psychedelic Research — Modern Science and Ancient Entheogen Parallels
Psychedelic research has undergone a dramatic revival since ~2006, with major studies at Johns Hopkins, Imperial College London, NYU, and MAPS demonstrating the therapeutic potential of psilocybin, MDMA, and ayahuasca/DM
Y_1_18 — Addiction Neurochemistry: Reward Circuits, Tolerance & Therapeutic Frontiers
Addiction — now formally termed substance use disorder (SUD, DSM-5) — is a chronic, relapsing brain disorder characterized by compulsive drug seeking despite harmful consequences, affecting approximately 35 million peopl
Y_1_15 — Micro-Dosing: Sub-Perceptual Psychedelic Use and Cognitive Effects
Micro-dosing — the practice of regularly consuming sub-perceptual doses (typically 1/10th to 1/20th of a standard recreational dose) of psychedelic substances, most commonly LSD (~10–20 micrograms) or psilocybin (~0.1–0.
Y_1_01 — Altered States, Psychedelics & Ancient Knowledge
Psychoactive substances played a significant — possibly central — role in ancient knowledge traditions. The Eleusinian Mysteries (kykeon), Vedic tradition (Soma), Egyptian practice (blue lotus), and Mesoamerican religion
H_4_16 — Pharmaceutical Suppression of Natural Remedies
The claim that the pharmaceutical industry systematically suppresses natural and herbal remedies to protect its patent-based profit model is one of the most widespread beliefs in alternative medicine — and one that conta
R_5_14 — Thermoregulation: Endothermy, Ectothermy, and Metabolic Evolution
Thermoregulation — the ability to maintain body temperature within functional limits — is a fundamental challenge of animal life, and the strategies organisms employ span a continuum from pure ectothermy (relying on envi
X_2_15 — Regenerative Medicine and Stem Cell Therapy
Regenerative medicine — defined as "the process of replacing, engineering, or regenerating human or animal cells, tissues, or organs to restore or establish normal function" — is among the most rapidly advancing frontier
X_2_12 — Sound Healing and Vibroacoustic Therapy
Sound healing encompasses a broad spectrum of practices — from ancient ritual use of chanting, drums, and singing bowls to modern clinical applications of vibroacoustic therapy (VAT), music therapy, and therapeutic ultra
X_5_26 — Psychedelic Medicine: The Johns Hopkins Center and the Therapeutic Renaissance
The psychedelic therapy renaissance — centered at the Johns Hopkins Center for Psychedelic and Consciousness Research (established 2019, originally launched as a research program in 2000) — represents one of the most sig
X_5_20 — Medical Regulation: Clinical Trials, Drug Safety, and the History of Oversight
Medical regulation — the system of laws, agencies, and protocols governing drug development, clinical trials, and medical device approval — evolved over centuries from virtually no oversight to the elaborate global frame
X_1_08 — Water & Healing: Hydrotherapy, Sacred Springs, Mineral Waters
Water has been the most universally venerated healing substance across human civilizations — from Mesopotamian purification rituals (3000 BCE) through Greek thermae, Roman bathhouse networks (900+ documented across the e
INTERDOC_72 — The Psychedelic Entropy Paradox: Coherence Through Anarchy
The "Entropic Brain" hypothesis, pioneered by Robin Carhart-Harris (Imperial College London), demonstrates that under the influence of classic psychedelics (psilocybin, LSD, DMT), the brain's Default Mode Network (DMN) d
Z_2_05 — Gene Therapy: History and Progress
Gene therapy — the introduction, alteration, or replacement of genetic material within a patient's cells to treat or cure disease — has evolved from a speculative concept to an approved clinical reality over five decades
Z_1_04 — Gene Expression and Regulation
Gene expression regulation — the molecular mechanisms controlling when, where, and how much each gene is active — is the central process that enables a single genome to produce ~200 distinct cell types, orchestrate embry
BROWSE BY SECTION — 3717 documents across 34 fields